Choi Kyoung-Hee, Schweizer Herbert P
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682, USA.
Nat Protoc. 2006;1(1):170-8. doi: 10.1038/nprot.2006.26.
We previously constructed a series of mini-Tn7 chromosome integration vectors that, when provided only with the site-specific transposition machinery, generally transpose to a naturally evolved, neutral attTn7 site that is located 25-bp downstream of the glmS gene. Here we provide a protocol for application of the mini-Tn7 system in Proteus mirabilis as an example of a bacterium with a secondary attTn7 site that is not linked to glmS but, in this case, located in the carAB operon. The procedure involves, first, cloning of the genes of interest into an appropriate mini-Tn7 vector; second, co-transfer of the recombinant mini-Tn7 vector and a helper plasmid encoding the Tn7 site-specific transposition pathway into P. mirabilis by transformation, followed by selection of insertion-containing strains; third, PCR verification of mini-Tn7 insertions; and last, optional Flp-mediated excision of the antibiotic-resistance selection marker present on the chromosomally integrated mini-Tn7 element. When transposon-containing cells are selected on rich medium, insertions occur at both attTn7 sites with equal efficiency and frequency. Because carA mutants are arginine and pyrimidine auxotrophs, single-site insertions at the glmS attTn7 sites can be obtained by selection on minimal medium. From start to verification of the insertion events, the whole procedure takes 5 d. This chromosome integration system in P. mirabilis provides an important tool for animal and biofilm studies based on this bacterium. Vectors are available for gene complementation and expression, gene fusion analyses and tagging with a green fluorescent protein (GFP)-encoding reporter gene.
我们之前构建了一系列微型Tn7染色体整合载体,这些载体在仅提供位点特异性转座机制时,通常会转座到一个自然进化的中性attTn7位点,该位点位于glmS基因下游25个碱基对处。在这里,我们以奇异变形杆菌为例,提供了一个在具有第二个attTn7位点的细菌中应用微型Tn7系统的方案,该位点与glmS基因不相连,而是位于carAB操纵子中。该过程首先是将感兴趣的基因克隆到合适的微型Tn7载体中;其次,通过转化将重组微型Tn7载体和编码Tn7位点特异性转座途径的辅助质粒共同导入奇异变形杆菌,随后筛选含插入片段的菌株;第三,通过PCR验证微型Tn7插入;最后,可选择通过Flp介导切除染色体整合的微型Tn7元件上存在的抗生素抗性选择标记。当在丰富培养基上选择含转座子的细胞时,插入会以相同的效率和频率发生在两个attTn7位点。由于carA突变体是精氨酸和嘧啶营养缺陷型,通过在基本培养基上选择,可以在glmS attTn7位点获得单一位点插入。从开始到验证插入事件,整个过程需要5天。奇异变形杆菌中的这种染色体整合系统为基于该细菌的动物和生物膜研究提供了一个重要工具。有可用于基因互补和表达、基因融合分析以及用编码绿色荧光蛋白(GFP)的报告基因进行标记的载体。